Carbonic anhydrase inhibitors
Introduction
Acetazolamide:
Renal effects:
More than 99% enzyme must be inhib. before physiol.effects apparent but acetazolamide potent reversible inhib. → 50% inhib. in renal cortex @ 10nm [];
inhib. of prox. tub. cytoplasmic carb.anhydrase:
inhib. of prox. tub. brush border carb.anhydrase:
THUS in urine:
Plasma Effects:
Eye effects:
CNS effects:
decr. CSF rate of formation; decr. epileptic seizures - ? via acidosis or incr. local CO2;
may transiently incr. CSF pressure via incr. cerebral blood flow;
may cause drowsiness, paraesthesiae; disorientation if hep.cirrhosis ( incr. ammonia?)
Resp. effects:
inhib. CO2 transport system → incr. CO2 in tissues & decr. CO2 in expired air;
P/K:
readily absorbed from GIT → peak 2hrs with complete excretion within 24hrs;
tightly bound to carbonic anhydrase → incr. [ ] in tissues with incr. [carb.anhyd.] (RBC's/renal);
not metabolised, solely excreted by kidneys with active secretion & passive reabs.;
dose: 250-500mg once every 1-2days if as diuretic or tds to induce metab.acidosis;
Interactions: